Serbia to Start Sale of Galenika Drugmaker in Early 2013
Serbia plans to start the sale of its drugmaker Galenika AD in early 2013, the government said in an e-mailed statement today.
The company posted a loss of 122 million euros ($160 million) in 2011.
To contact the reporter on this story: Misha Savic in Belgrade at email@example.com
To contact the editor responsible for this story: James M. Gomez at firstname.lastname@example.org